Skip to content

Addressing psycho-social needs in patients with Long-Covid - a pilot study

Addressing psycho-social needs in patients with Long-Covid - a pilot study - PsyLoCo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030866
Enrollment
120
Registered
2023-03-07
Start date
2023-03-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-Covid, Post-Covid U09.9!

Interventions

Group 1: Intervention group The intervention group will beginn with the psychotherapeutic treatment according to a manual consisting of 12 sessions. The intervention will focus on the following thera

Sponsors

Klinikum rechts der Isar der TU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Previous COVID-19-infection (at least 4 weeks ago) • At least one symptom of Long-COVID • Written consent • Suitable place of residence to attend the appointments at one of the locations • Availability during intervention period

Exclusion criteria

Exclusion criteria: • Severe psychiatric illness according to ICD-10 (F0, F1, F2, F31) • Suicidality • Currently receiving psychotherapeutic treatment or having received psychotherapeutic treatment for Long-COVID • Insufficient German language skills • Lack of capacity to give consent

Design outcomes

Primary

MeasureTime frame
Improvement of (health-related) quality of life as measured by self-reported questionnaires (SF-12) The SF-12 will be completed before starting with the therapeutic intervention (t1), after completing the last therapy session (t2) and 3 months after ending the intervention (t3)

Secondary

MeasureTime frame
Via self-reported questionnaired: • Improvement/changes of somatic symptoms as well as other Long-COVID-related symptoms like fatigue, stress, symptoms of depression or anxiety (at t1, t2 and t3) • Improvement/changes of ability to work or fulfill daily demands; beliefs and feelings about the illness (at t1, t2 and t3) • Satisfaction with the intervention (at t2 and t3) Via blood collection • Cytokine profiling and possible changes

Countries

Germany

Contacts

Public ContactChristine Allwang

Klinikum rechts der Isar der TU München; Klinik für Psychosomatische Medizin und Psychotherapie

christine.allwang@mri.tum.de+498941404319

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026